ATAD2 Knockout HAP1 Cell Line

The choice depends on whether you are studying ATAD2 (ATPase family AAA domain containing 2)'s role as a bromodomain-containing AAA+ ATPase or modeling its emerging functions as a cancer target. The Knockout line is the standard tool for asking whether ATAD2 is required for these processes — ATAD2 is an unusual protein combining AAA+ ATPase domain and a bromodomain (acetyl-lysine reader), with reported roles as a histone chaperone-like activity, MYC coactivator, and oncogenic driver; ATAD2 is overexpressed in many cancers and correlates with poor prognosis. Overexpression is useful for studying ATAD2 gain-of-function effects. For cancer drug development research, the EDITGENE ATAD2 Knockout in HAP1 provides a clean genetic background for characterizing ATAD2-specific functions. Rescue with wild-type, ATPase-dead, or bromodomain-mutant ATAD2 enables structure-function studies. The knockout is a critical specificity tool for emerging ATAD2-selective bromodomain inhibitors (GSK8814, BAY-850, AT19) in cancer drug development — ATAD2 has been characterized as a promising 'undruggable' cancer target now accessible through chemical biology approaches.

Primary applications: • ATAD2-selective bromodomain inhibitor specificity: critical genetic control for GSK8814, BAY-850, AT19 in cancer drug development. • MYC coactivator function: in heterologous MYC-driven contexts, ATAD2's role as a MYC coactivator. • Chromatin biology: acetyl-histone binding and chromatin association analysis in ATAD2-null cells. • Cancer prognosis biomarker: ATAD2 expression analysis in cancer context. EDITGENE recommends this model for researchers investigating ATAD2 biology and emerging ATAD2-targeted bromodomain inhibitor cancer drug development.

Yes. ATAD2 rescue experiments are uniquely useful for the dual-domain architecture: • Construct design: use a codon-modified ATAD2 sequence with a small C-terminal tag (FLAG, HA). ATAD2 has central AAA+ ATPase domain and C-terminal bromodomain — preserve all elements. • ATPase-dead rescue: Walker A or Walker B motif mutations abolish ATPase activity. • Bromodomain-mutant rescue: N1064F asparagine mutation in the acetyl-lysine binding pocket abolishes acetyl-mark recognition. • Functional readout: rescue should restore ATAD2-dependent phenotypes; bromodomain-mutant rescue tests the specific contribution of acetyl-mark reading. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.